Fri 8/1/2014 01:45 ET
DJIA16563.30311.391.88%SOLAR39.421.132.86%GOLD1282.900.930.93%Shanghai2203.081.540.07%
S&P 5001930.6738.612.00%BANKS22.410.462.05%OIL98.01220.522.25%Nikkei15570.2149.820.32%
NASDAQ4369.7791.332.09%SEMI48.760.921.89%US/EU0.750.030.04%Futures1928.503.700.19%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Applied Science & Technology Inc - ASTX   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add ASTX
  
From: all2tropical (Rep: 203)Date: 02/09/2012 13:47
Forum: Applied Science & Technology Inc - Msg #7Thread #673358445 (Rec: 0)
another one bites the dust...(H) DJ FDA's Oncologic Drugs Advisory Committee (ODAC) Votes To Not Support Benefit/Risk Profile Of DACOGEN(R) (decitabine) In Acute Myeloid Leukemia >ASTX
(MORE TO FOLLOW) Dow Jones Newswires (212-416-2400) February 09, 2012 13:46 ET (18:46 GMT) Copyright (c) 2012 Dow Jones & Company, Inc.- - 01 46 PM EST 02-09-12



Share This Post:


http://www.kirkreport.com/pictures/sumo_market.gif



***Disclaimer & Disclosure***: I make no guarantee as to the accuracy or validity of information in this message... 

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser all2tropical: Reward | Watch | IgnoreASTX: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add ASTX
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.